Efficacy of cytokine-induced killer therapy following operation of renal cell carcinoma in north China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of cytokine-induced killer therapy following operation of renal cell carcinoma in north China

Published:2020-12 Issue:8 Volume:32 Page:3200-3206
ISSN:1018-3647
Container-title:Journal of King Saud University - Science
language:en
Short-container-title:Journal of King Saud University - Science

Author:

Lv Jiaju,Liu Xiaoli,Fu Qiang,Zhang Keqin,Ding Sentai,Song Wanmei,Li Xin,Zhang Hui,Sun Dingqi,Liu Shuai

Funder

Natural Science Foundation of Shandong Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference24 articles.

1. Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival-a substudy of the MIMOSA trial;Buzzonetti;Cancer Immunol. Immunother.,2014

2. Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells;Cappuzzello;Cytokine Growth Factor Rev.,2017

3. Cancer statistics in China, 2015.Ca;Chen;Cancer J. Clin.,2015

4. Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomy;Gbormittah;J. Proteome Res.,2014

5. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway;Iudicone;Hum. Immunol.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP